United States

ResMed Inc. RMD

NYSE Health technology USD

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. The company operates through two primary segments: Sleep and Breathing Health, and Residential Care Software. Its core products include a range of CPAP, APAP, and bilevel machines, ventilation devices, and a variety of masks designed to provide effective and comfortable therapy for patients with sleep-disordered breathing. ResMed also offers portable diagnostic devices and comprehensive digital health platforms like AirView and myAir, which enable remote patient monitoring and therapy management. The company serves patients, healthcare providers, and residential care organizations worldwide, with a business model centered on recurring revenue from mask replacements and software subscriptions alongside device sales. Through its software subsidiaries—Brightree, HEALTHCAREfirst, MatrixCare, and MEDIFOX DAN—ResMed provides cloud-based healthcare IT solutions that help home medical equipment providers, home health and hospice agencies, skilled nursing facilities, and senior living communities optimize their clinical, financial, and administrative operations.

Current Price USD 246.52
Daily Change -1.41%
Market Cap USD 35.98 B
Shares Outstanding 145.97 M
Forecast

LSTM Forecast

Forecast model is not trained yet for this market.

Next 5 Trading Days

Train and backfill the LSTM forecast to surface a directional view here.

Chart